DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. OCRP Research Highlights/News
  3. 2015 Ovarian Cancer Research Program

NEWS RELEASE

Released: February 19, 2015

Department of Defense Ovarian Cancer Research Program
Funding Opportunities for Fiscal Year 2015 (FY15)

The FY15 Defense Appropriations Act provides $20 million (M) to the Department of Defense Ovarian Cancer Research Program (OCRP) to support high-impact ovarian cancer research. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate manages and executes the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The executing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

The OCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY15 OCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in March 2015. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government. Funding is contingent on receipt of appropriations.

Award Mechanism PI Eligibility Key Mechanism Elements Funding
Clinical Translational Award Must be an independent investigator at or above the level of Assistant Professor (or equivalent)
  • Supports translational research addressing high-impact ideas in ovarian cancer
  • Supports pre-clinical and clinical research, and clinical trial-related research
  • Clinical trials are not allowed
  • Preliminary data are required
  • Pre-application is required; application is by invitation only
  • Maximum funding of $300,000 in direct costs (plus indirect costs)
  • Period of performance should not exceed 3 years
Investigator-Initiated Research Award Must be an independent investigator at or above the level of Assistant Professor (or equivalent)
  • Supports meritorious basic and clinically oriented research in ovarian cancer
  • Impact is an important review criterion.
  • Preliminary data are required
  • Clinical trials are not allowed
  • Pilot awardees (past & present) are encouraged to apply
  • Pre-application is required; application is by invitation only
  • Maximum funding of $450,000 in direct costs (plus indirect costs)
  • Period of performance should not exceed 3 years
Ovarian Cancer Academy Award - Early-Career Investigator Early-Career Investigator must be within the first 3 years of his/her first faculty position (or equivalent) at the time of submission. The first faculty position (or equivalent) may be either tenure-track or non-tenure track.

Designated Mentor must be an independent ovarian cancer researcher
  • Supports the addition of new Early-Career Investigators to the unique, interactive virtual academy that will provide intensive mentoring, national networking, and a peer group for junior faculty
  • Early-Career Investigators from less ovarian cancer-resourced organizations are encouraged to apply
  • Designated mentor who is an experienced ovarian cancer researcher with ovarian cancer funding is required
  • Preliminary data are required
  • Institutional match of $50,000 per year is required
  • Pre-application is required; application is by invitation only
  • Maximum funding of $725,000 in direct costs (plus indirect costs)
  • Period of performance of 5 years
Pilot Award Investigators at or above the postdoctoral level (or equivalent)
  • Supports innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer research forward
  • Innovation and Impact are important review criteria
  • Preliminary data are not required, but allowed
  • Clinical trials are not allowed
  • Pre-application is required and is blinded; application submission is by invitation only
  • Maximum funding of $250,000 in direct costs (plus indirect costs)
  • Period of performance should not exceed 2 years

All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. Requests for email notification of the Program Announcements release may be sent to help@eBRAP.org. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.

For more information about the OCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Public Affairs
301-619-9783
usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil